posted on 2024-03-07, 18:34authored byAna Ruigómez, Tania Schink, Annemarie Voss, Ron M. C. Herings, Elisabeth Smits, Karin Swart-Polinder, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Luis Alberto García Rodríguez
General characteristics of study patients: First-time users of rivaroxaban or VKA for the treatment and secondary prevention of VTE.